Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
John Frederick Ek | CFO | 2025-04-01 | 16,432 | $1.35 | $22.18kSell |
Niro Phd Ramachandran | Chief Business Officer | 2025-03-23 | 2,310 | $1.70 | $3.93kSell |
Brian McKelligon | President and CEO | 2025-03-23 | 7,550 | $1.70 | $12.84kSell |
Jennifer Kamocsay | Chief Legal Officer | 2025-03-01 | 3,851 | $1.63 | $6.28kSell |
Jennifer Kamocsay | Chief Legal Officer | 2025-03-01 | 3,594 | $1.63 | $5.86kSell |
Pascal Bamford | Chief Clinical Officer | 2025-03-01 | 1,283 | $1.63 | $2.09kSell |
Pascal Bamford | Chief Clinical Officer | 2025-03-01 | 2,567 | $1.63 | $4.18kSell |
John Frederick Ek | CFO | 2025-03-01 | 3,594 | $1.63 | $5.86kSell |
Brian McKelligon | President and CEO | 2025-03-01 | 7,550 | $1.63 | $12.31kSell |
Brian McKelligon | President and CEO | 2025-03-01 | 8,257 | $1.63 | $13.46kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Thomas A. Raffin | 33.33% | 16,601,311 | $18.26M | Insider |
Thomas P. Schnettler | 11.15% | 5,556,492 | $6.11M | Insider |
Blue Water Life Science Advisors LP | 9.43% | 4,697,785 | $5.17M | Institution |
Blackrock Inc | 3.29% | 1,637,330 | $1.80M | Institution |
Vanguard Group Inc | 2.82% | 1,407,062 | $1.55M | Institution |
Matthew Winkler | 1.98% | 984,513 | $1.08M | Insider |
Paragon Associates Paragon Associates II Joint Venture | 1.61% | 801,000 | $881.10k | Institution |
Robert G. Shepler | 1.55% | 774,184 | $851.60k | Insider |
Geode Capital Management LLC | 1.14% | 565,489 | $622.04k | Institution |
Garry Phd Nolan | 1.11% | 555,084 | $610.59k | Insider |